MRg-NIRS Imaging System Breast Cancer Trial

Recruiting N/A Interventional Study
Breast Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 83
Sex
Female
Study type
Interventional
Purpose
Device Feasibility
Participants needed
20 (estimated)
Sponsor
Keith D. Paulsen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This trial is a study of 20 women with breast cancer to evaluate the addition of MR-guided (MRg) near-infrared spectroscopy (NIRS) with and without contrast, as part of a program to improve clinical management of women receiving breast magnetic resonance imaging (MRI).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Females age ≥ 18 years old 2. Participants capable of providing written informed consent 3. Women with a recent diagnosis of breast cancer. 4. Women who are in pre-surgical planning must have an estimated tumor size of 2.0 cm or less on available imaging. 5. Women who are in …
Contacts

Keith D. Paulsen, PhD

603-646-2695

Keith.D.Paulsen@Dartmouth.edu

CONTACT

Shudong Jiang, PhD

Shudong.Jiang@Dartmouth.edu

CONTACT